Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.

p53, the Cellular Gatekeeper for Growth and Division

1997 • 7,621 citations

Rising Incidence of Adenocarcinoma of the Esophagus and nGastric Cardia

1991 • 2,278 citations

Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27

1995 • 1,848 citations

Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors

1996 • 1,583 citations

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas

1997 • 1,055 citations

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1997 • 929 citations

Observer variation in the diagnosis of dysplasia in Barrett's esophagus

1988 • 788 citations

Barrett's esophagus, dysplasia, and adenocarcinoma

1994 • 647 citations

Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

1995 • 549 citations

Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.

1997 • 428 citations

The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.

1997 • 354 citations

Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.

1998 • 329 citations

A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis

1996 • 109 citations

Current concepts concerning the nature and treatment of Barrett's esophagus and its complications

1992 • 35 citations